You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The Endurant™ family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA).
Contact UsEndurant IIs stent graft is a three-piece system that:
Accurate placement and controlled deployment.2 Flexible, kink-resistant delivery system facilitates stent graft delivery. Tip capture for precise positioning adjustments, including adjustment of placement proximally or distally.
Continuous seal, fixation, and graft conformability.3 M-shaped proximal stents provide wall apposition and circumferential conformability.
Durable hemostatic barrier and resistance against type II endoleaks.4 High density, multifilament polyester graft material provides lower porosity for resistance against type II endoleaks.
Deployment, capture, and release of the Endurant II stent.
Deployment of the Endurant II Stent Graft - (03:05)
View an animation of the Endurant II stent deployment.
More information (see more)
Less information (see less)
Deployment of the Endurant IIs Stent Graft - (06:34)
View an animation of the Endurant IIs stent graft deployment.
More information (see more)
Less information (see less)
All indications related to Endurant II/IIs Stent Graft System are not approved globally. Please check your local regulatory approval status. Refer to the complete Instructions for Use manual of the Endurant II/IIs stent graft system for the indications approved in your geography.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic Europe website.
The Endurant II/IIs stent graft system is indicated for the endovascular treatment of infrarenal or juxtarenal abdominal aortic or aortoiliac aneurysms in patients with the following characteristics:
In addition, for treatment of infrarenal abdominal aortic or aortoiliac aneurysms, the following patient characteristics apply:
In addition, for treatment of juxtarenal abdominal aortic or aortoiliac aneurysms with the parallel graft technique,† the following patient characteristics apply:
Note: The angle between the aortic and renal artery blood lumen centerlines is the renal take-off angulation. An angle of < 90° is associated with a downward-pointed renal artery relative to the trajectory of the aortic centerline.
†These indications are not approved for use by FDA. Please refer to the brief statement for indications for use in the United States.
Find this technical manual in the Medtronic Manual Library, in the product labeling supplied with each device, or by calling 1-877-526-7890.
Use this tool to plan case specifics such as sizing and placement.
215KB
Download Sizing SheetProximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETBF | 23 | 13 | C | 124 | EE | 18 |
ETBF | 23 | 13 | C | 145 | EE | 18 |
ETBF | 23 | 13 | C | 166 | EE | 18 |
ETBF | 23 | 16 | C | 124 | EE | 18 |
ETBF | 23 | 16 | C | 145 | EE | 18 |
ETBF | 23 | 16 | C | 166 | EE | 18 |
ETBF | 25 | 13 | C | 124 | EE | 18 |
ETBF | 25 | 13 | C | 145 | EE | 18 |
ETBF | 25 | 13 | C | 166 | EE | 18 |
ETBF | 25 | 16 | C | 124 | EE | 18 |
ETBF | 25 | 16 | C | 145 | EE | 18 |
ETBF | 25 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 13 | C | 124 | EE | 18 |
ETBF | 28 | 13 | C | 145 | EE | 18 |
ETBF | 28 | 13 | C | 166 | EE | 18 |
ETBF | 28 | 16 | C | 124 | EE | 18 |
ETBF | 28 | 16 | C | 145 | EE | 18 |
ETBF | 28 | 16 | C | 166 | EE | 18 |
ETBF | 28 | 20 | C | 124 | EE | 18 |
ETBF | 28 | 20 | C | 145 | EE | 18 |
ETBF | 28 | 20 | C | 166 | EE | 18 |
ETBF | 32 | 16 | C | 124 | EE | 20 |
ETBF | 32 | 16 | C | 145 | EE | 20 |
ETBF | 32 | 16 | C | 166 | EE | 20 |
ETBF | 32 | 20 | C | 124 | EE | 20 |
ETBF | 32 | 20 | C | 145 | EE | 20 |
ETBF | 32 | 20 | C | 166 | EE | 20 |
ETBF | 36 | 16 | C | 145 | EE | 20 |
ETBF | 36 | 16 | C | 166 | EE | 20 |
ETBF | 36 | 20 | C | 145 | EE | 20 |
ETBF | 36 | 20 | C | 166 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ESBF | 23 | 14 | C | 103 | EE | 18 |
ESBF | 25 | 14 | C | 103 | EE | 18 |
ESBF | 28 | 14 | C | 103 | EE | 18 |
ESBF | 32 | 14 | C | 103 | EE | 20 |
ESBF | 36 | 14 | C | 103 | EE | 20 |
Distal Graft |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
Total Contralateral Covered Length with EII/EIIs Bifurcated§ |
Total Ipsilateral Covered Length with EIIs Bifurcated|| |
|
---|---|---|---|---|---|---|---|---|
ETLW | 16 | 10 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 10 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 10 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 10 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 10 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 10 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 13 | C | 82 | EE | 14 | 136 | 155 |
ETLW | 16 | 13 | C | 93 | EE | 14 | 147 | 166 |
ETLW | 16 | 13 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 10 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 13 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 13 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 16 | C | 82 | EE | 14 | 136 | 135–155 |
ETLW | 16 | 16 | C | 93 | EE | 14 | 147 | 146–166 |
ETLW | 16 | 16 | C | 124 | EE | 14 | 178 | 177–197 |
ETLW | 16 | 13 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 16 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 16 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 20 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 20 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 20 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 16 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 20 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 20 | C | 199 | EE | 16 | 253 | 252-272 |
ETLW | 16 | 24 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 24 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 24 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 24 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 24 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 24 | C | 199 | EE | 16 | 253 | 252–272 |
ETLW | 16 | 28 | C | 82 | EE | 16 | 136 | 155 |
ETLW | 16 | 28 | C | 93 | EE | 16 | 147 | 166 |
ETLW | 16 | 28 | C | 124 | EE | 16 | 178 | 177–197 |
ETLW | 16 | 28 | C | 146 | EE | 16 | 196 | 196-216 |
ETLW | 16 | 28 | C | 156 | EE | 16 | 210 | 209–229 |
ETLW | 16 | 28 | C | 199 | EE | 16 | 253 | 252–272 |
‡The limb mates with the AUI stent graft on the ipsilateral side.
§These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions for Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.
||The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.
Proximal |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETCF | 23 | 23 | C | 49 | EE | 18 |
ETCF | 25 | 25 | C | 49 | EE | 18 |
ETCF | 28 | 28 | C | 49 | EE | 18 |
ETCF | 32 | 32 | C | 49 | EE | 20 |
ETCF | 36 | 36 | C | 49 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETTF | 23 | 23 | C | 70 | EE | 18 |
ETTF | 25 | 25 | C | 70 | EE | 18 |
ETTF | 28 | 28 | C | 70 | EE | 18 |
ETTF | 32 | 32 | C | 70 | EE | 20 |
ETTF | 36 | 36 | C | 70 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETUF | 23 | 14 | C | 102 | EE | 18 |
ETUF | 25 | 14 | C | 102 | EE | 18 |
ETUF | 28 | 14 | C | 102 | EE | 18 |
ETUF | 32 | 14 | C | 102 | EE | 20 |
ETUF | 36 | 14 | C | 102 | EE | 20 |
Proximal Graft Diameter (mm) |
Distal Graft Diameter (mm) |
Distal Design |
Total Covered Length (mm) |
Delivery System |
Catheter Outer Diameter (F) |
|
---|---|---|---|---|---|---|
ETEW | 10 | 10 | C | 82 | EE | 14 |
ETEW | 13 | 13 | C | 82 | EE | 14 |
ETEW | 20 | 20 | C | 82 | EE | 16 |
ETEW | 24 | 24 | C | 82 | EE | 16 |
ETEW | 28 | 28 | C | 82 | EE | 18 |
Choose from a complete portfolio of market-leading aortic vascular therapies to treat aneurysm disease.
Download CatalogDelivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the U.S. regulatory trial of the Endurant™ stent graft system.
These indications are not approved for use by FDA. Please refer to the brief statement for indications for use in the United States.
The limb mates with the AUI stent graft on the ipsilateral side.
These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions for Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.
The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.
Data on file Medtronic.
Makaroun M Tuchek M, Massop D, et al. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. September 2011;54(3):601–608. Endurant™ US IDE trial.
Based on internal test report DVR7245 Design Verification Report: Endurant Stent Graft System conducted January–July 2007. Bench test data may not be indicative of clinical performance.
Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234–243.